Skip to main navigation
Skip to search
Skip to main content
Sort by
Biochemistry, Genetics and Molecular Biology
Non-Homologous End Joining
100%
DNA Repair
92%
Transposase
69%
Endonuclease
62%
Double-Strand DNA Break
58%
Homologous Recombination
55%
BRCA1
52%
Genome Instability
46%
DNA Damage
44%
Chromosomal Translocation
42%
Myeloid
41%
DNA Gyrase
39%
Nuclease
35%
Cancer Cell
35%
phosphorylation
34%
Histone H3
30%
Chromosome
30%
Promoter Region
29%
Synthetic Lethality
29%
Methylation
28%
Poly ADP Ribose Polymerase
26%
Phosphatase
26%
Histone
25%
Lysine
25%
Exonuclease
23%
Oncogene C Myc
23%
Phosphotransferase
23%
Kinase
23%
Transcription
23%
DNA Damage Response
22%
Transcription Initiation
21%
Methyltransferase
20%
Genomics
20%
Enzyme
20%
Histone Methylation
20%
Signal Transduction
20%
Carcinogenesis
19%
Synapsin I
19%
Ubiquitination
18%
Ccaat-Enhancer-Binding Proteins
18%
Exonuclease 1
18%
Transactivation
17%
DNA Binding
17%
Recombination Repair
16%
RAD51
16%
Hematopoietic Cell
16%
Chromatin
16%
USP1
15%
Wild Type
15%
Base Excision Repair
14%
Immunology and Microbiology
Transformed Cell
30%
Myeloid
28%
Kinase
27%
Phosphotransferase
27%
Promoter Region
23%
Transposase
20%
DNA Repair
18%
Oncogene C Myc
18%
DNA End Joining Repair
14%
phosphorylation
12%
Hematopoietic Cell
11%
Amino Terminal Sequence
11%
Cyclin D1
9%
Tyrosine
9%
Tumor Suppressor Gene
9%
Cell Cycle Progression
9%
Methylation
9%
Histone Code
9%
Mitogen
9%
Phosphatase
9%
Host Cell
9%
CCAAT Enhancer Binding Protein
9%
Hedgehog Signaling
9%
Signal Transduction
9%
DNA Damage
9%
Oncogene
9%
Oncogene C Fos
9%
Transcription Initiation
9%
Hematopoiesis
9%
Cell Cycle
8%
Cell Extract
7%
Ciclosporin
6%
Ribonucleic Acid
5%
Wild Type
5%
Interleukin 3
5%
In Vitro
5%
Cell Cycle G1 Phase
5%
Pharmacology, Toxicology and Pharmaceutical Science
Troglitazone
37%
Breast Cancer
24%
Peroxisome Proliferator Activated Receptor
23%
Retinoid
18%
Prostate Cancer
18%
Malignant Neoplasm
16%
Pancreas Cancer
15%
Retinoic Acid Receptor
15%
Retinoic Acid
13%
Gemcitabine
9%
Drug Resistance
9%
Multidrug Resistance
9%
Histone
9%
DNA Topoisomerase (ATP Hydrolysing)
9%
Peroxisome Proliferator Activated Receptor Gamma
9%
Phosphotransferase
9%
Androgen
9%
Peroxisome Proliferator
9%
Transposase
9%
Cytotoxicity
9%
Lethality
9%
Myeloid Leukemia
9%
Acute Leukemia
9%
Gyrase Inhibitor
9%
Anthracycline
8%
Chemotherapy Regimens
8%
Colon Carcinoma
7%
Retinoid X Receptor
6%
Leukemia
5%